Alterations in marginal zone macrophages and marginal zone B cells in old mice

Journal of Immunology

Volumn 186, Issue 6, 2011, Pages 3441-3451

  Birjandi, Shirin Z ^a   Ippolito, Jill A ^a   Ramadorai, Anand K ^a   Witte, Pamela L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1;

AGE; AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; FEMALE; LYMPHOCYTE COUNT; MACROPHAGE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN; STAPHYLOCOCCUS AUREUS;

AGE FACTORS; AGING; ANIMALS; ANTIGENS; B-LYMPHOCYTE SUBSETS; CELL ADHESION; CELL COUNT; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPHOPENIA; MACROPHAGES; MICE; MICE, INBRED BALB C; SPLEEN;

EID: 79953225865     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1001271     Document Type: Article

References (62)

1. Artz, A. S., W. B. Ershler, and D. L. Longo. 2003. Pneumococcal vaccination and revaccination of older adults. Clin. Microbiol. Rev. 16: 308-318.
2. van der Poll, T., and S. M. Opal. 2009. Pathogenesis, treatment, and prevention of pneumococcal pneumonia. Lancet 374: 1543-1556.
3. Bondada, S., H. Wu, D. A. Robertson, and R. L. Chelvarajan. 2000. Accessory cell defect in unresponsiveness of neonates and aged to polysaccharide vaccines. Vaccine 19: 557-565.
4. Butler, J. C., E. D. Shapiro, and G. M. Carlone. 1999. Pneumococcal vaccines: history, current status, and future directions. Am. J. Med. 107(1A): 69S-76S.
5. Kirby, A. C., L. Beattie, A. Maroof, N. van Rooijen, and P. M. Kaye. 2009. SIGNR1-negative red pulp macrophages protect against acute streptococcal sepsis after Leishmania donovani-induced loss of marginal zone macrophages. Am. J. Pathol. 175: 1107-1115.
6. Mebius, R. E., and G. Kraal. 2005. Structure and function of the spleen. Nat. Rev. Immunol. 5: 606-616.
7. Kraal, G., and R. Mebius. 2006. New insights into the cell biology of the marginal zone of the spleen. Int. Rev. Cytol. 250: 175-215.
8. Lanoue, A., M. R. Clatworthy, P. Smith, S. Green, M. J. Townsend, H. E. Jolin, K. G. Smith, P. G. Fallon, and A. N. McKenzie. 2004. SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J. Exp. Med. 200: 1383-1393.
9. Kang, Y. S., S. Yamazaki, T. Iyoda, M. Pack, S. A. Bruening, J. Y. Kim, K. Takahara, K. Inaba, R. M. Steinman, and C. G. Park. 2003. SIGN-R1, a novel C-type lectin expressed by marginal zone macrophages in spleen, mediates uptake of the polysaccharide dextran. Int. Immunol. 15: 177-186.
10. Dijkstra, C. D., E. Van Vliet, E. A. Döpp, A. A. van der Lelij, and G. Kraal. 1985. Marginal zone macrophages identified by a monoclonal antibody: characterization of immuno- and enzyme-histochemical properties and functional capacities. Immunology 55: 23-30.
11. Gunn, K. E., and J. W. Brewer. 2006. Evidence that marginal zone B cells possess an enhanced secretory apparatus and exhibit superior secretory activity. J. Immunol. 177: 3791-3798.
12. Allman, D., and S. Pillai. 2008. Peripheral B cell subsets. Curr. Opin. Immunol. 20: 149-157.
13. Vos, Q., A. Lees, Z. Q. Wu, C. M. Snapper, and J. J. Mond. 2000. B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol. Rev. 176: 154-170.
14. Chelvarajan, R. L., S. M. Collins, J. M. Van Willigen, and S. Bondada. 2005. The unresponsiveness of aged mice to polysaccharide antigens is a result of a defect in macrophage function. J. Leukoc. Biol. 77: 503-512.
15. Elomaa, O., M. Kangas, C. Sahlberg, J. Tuukkanen, R. Sormunen, A. Liakka, I. Thesleff, G. Kraal, and K. Tryggvason. 1995. Cloning of a novel bacteria-binding receptor structurally related to scavenger receptors and expressed in a subset of macrophages. Cell 80: 603-609.
16. Karlsson, M. C., R. Guinamard, S. Bolland, M. Sankala, R. M. Steinman, and J. V. Ravetch. 2003. Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J. Exp. Med. 198: 333-340.
17. Koppel, E. A., E. Saeland, D. J. de Cooker, Y. van Kooyk, and T. B. Geijtenbeek. 2005. DC-SIGN specifically recognizes Streptococcus pneumoniae serotypes 3 and 14. Immunobiology 210: 203-210.
18. Geijtenbeek, T. B., P. C. Groot, M. A. Nolte, S. J. van Vliet, S. T. Gangaram-Panday, G. C. van Duijnhoven, G. Kraal, A. J. van Oosterhout, and Y. van Kooyk. 2002. Marginal zone macrophages express a murine homologue of DCSIGN that captures blood-borne antigens in vivo. Blood 100: 2908-2916.
19. Kang, Y. S., J. Y. Kim, S. A. Bruening, M. Pack, A. Charalambous, A. Pritsker, T. M. Moran, J. M. Loeffler, R. M. Steinman, and C. G. Park. 2004. The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide of Streptococcus pneumoniae in the marginal zone of mouse spleen. Proc. Natl. Acad. Sci. USA 101: 215-220.
20. Koppel, E. A., C.W.Wieland, V. C. van den Berg, M. Litjens, S. Florquin, Y. van Kooyk, T. van der Poll, and T. B. Geijtenbeek. 2005. Specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) expressed by marginal zone macrophages is essential for defense against pulmonary Streptococcus pneumoniae infection. Eur. J. Immunol. 35: 2962-2969.
21. Koppel, E. A., M. Litjens, V. C. van den Berg, Y. van Kooyk, and T. B. Geijtenbeek. 2008. Interaction of SIGNR1 expressed by marginal zone macrophages with marginal zone B cells is essential to early IgM responses against Streptococcus pneumoniae. Mol. Immunol. 45: 2881-2887.
22. Chen, Y., T. Pikkarainen, O. Elomaa, R. Soininen, T. Kodama, G. Kraal, and K. Tryggvason. 2005. Defective microarchitecture of the spleen marginal zone and impaired response to a thymus-independent type 2 antigen in mice lacking scavenger receptors MARCO and SR-A. J. Immunol. 175: 8173-8180.
23. Gebe, J. A., M. Llewellyn, H. Hoggatt, and A. Aruffo. 2000. Molecular cloning, genomic organization and cell-binding characteristics of mouse Spalpha. Immunology 99: 78-86.
24. Yokota, T., B. Ehlin-Henriksson, and G. K. Hansson. 1998. Scavenger receptors mediate adhesion of activated B lymphocytes. Exp. Cell Res. 239: 16-22.
25. Szakal, A. K., Y. Aydar, P. Balogh, and J. G. Tew. 2002. Molecular interactions of FDCs with B cells in aging. Semin. Immunol. 14: 267-274.
26. Eaton-Bassiri, A. S., L. Mandik-Nayak, S. J. Seo, M. P. Madaio, M. P. Cancro, and J. Erikson. 2000. Alterations in splenic architecture and the localization of anti-double-stranded DNA B cells in aged mice. Int. Immunol. 12: 915-926.
27. Minges Wols, H. A., K. M. Johnson, J. A. Ippolito, S. Z. Birjandi, Y. Su, P. T. Le, and P. L. Witte. 2010. Migration of immature and mature B cells in the aged microenvironment. Immunology 129: 278-290.
28. Cheung, H. T., and M. J. Nadakavukaren. 1983. Age-dependent changes in the cellularity and ultrastructure of the spleen of Fischer F344 rats. Mech. Ageing Dev. 22: 23-33.
29. Zheng, B., S. Han, Y. Takahashi, and G. Kelsoe. 1997. Immunosenescence and germinal center reaction. Immunol. Rev. 160: 63-77.
30. Cinamon, G., M. A. Zachariah, O. M. Lam, F. W. Foss, Jr., and J. G. Cyster. 2008. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 9: 54-62.
31. Ato, M., H. Nakano, T. Kakiuchi, and P. M. Kaye. 2004. Localization of marginal zone macrophages is regulated by C-C chemokine ligands 21/19. J. Immunol. 173: 4815-4820.
32. Won, W. J., J. B. Foote, M. R. Odom, J. Pan, J. F. Kearney, and R. S. Davis. 2006. Fc receptor homolog 3 is a novel immunoregulatory marker of marginal zone and B1 B cells. J. Immunol. 177: 6815-6823.
33. Mebius, R. E., M. A. Nolte, and G. Kraal. 2004. Development and function of the splenic marginal zone. Crit. Rev. Immunol. 24: 449-464.
34. Pillai, S., A. Cariappa, and S. T. Moran. 2005. Marginal zone B cells. Annu. Rev. Immunol. 23: 161-196.
35. Jablonska, J., K. E. Dittmar, T. Kleinke, J. Buer, and S. Weiss. 2007. Essential role of CCL2 in clustering of splenic ERTR-9+ macrophages during infection of BALB/c mice by Listeria monocytogenes. Infect. Immun. 75: 462-470.
36. Nolte, M. A., R. Arens, M. Kraus, M. H. van Oers, G. Kraal, R. A. van Lier, and R. E. Mebius. 2004. B cells are crucial for both development and maintenance of the splenic marginal zone. J. Immunol. 172: 3620-3627.
37. Frasca, D., A. M. Landin, S. C. Lechner, J. G. Ryan, R. Schwartz, R. L. Riley, and B. B. Blomberg. 2008. Aging down-regulates the transcription factor E2A, activation-induced cytidine deaminase, and Ig class switch in human B cells. J. Immunol. 180: 5283-5290.
38. Weill, J. C., S. Weller, and C. A. Reynaud. 2009. Human marginal zone B cells. Annu. Rev. Immunol. 27: 267-285.
39. Takeya, M., and K. Takahashi. 1992. Ontogenic development of macrophage subpopulations and Ia-positive dendritic cells in fetal and neonatal rat spleen. J. Leukoc. Biol. 52: 516-523.
40. Katakai, T., H. Suto, M. Sugai, H. Gonda, A. Togawa, S. Suematsu, Y. Ebisuno, K. Katagiri, T. Kinashi, and A. Shimizu. 2008. Organizer-like reticular stromal cell layer common to adult secondary lymphoid organs. J. Immunol. 181: 6189-6200.
41. Siegrist, C. A., and R. Aspinall. 2009. B-cell responses to vaccination at the extremes of age. Nat. Rev. Immunol. 9: 185-194.
42. van Rooijen, N., N. Kors, and G. Kraal. 1989. Macrophage subset repopulation in the spleen: differential kinetics after liposome-mediated elimination. J. Leukoc. Biol. 45: 97-104.
43. Khanna, K. M., D. A. Blair, A. T. Vella, S. J. McSorley, S. K. Datta, and L. Lefrançois. 2010. T cell and APC dynamics in situ control the outcome of vaccination. J. Immunol. 185: 239-252.
44. Allman, D., and J. P. Miller. 2005. B cell development and receptor diversity during aging. Curr. Opin. Immunol. 17: 463-467.
45. Lopes-Carvalho, T., and J. F. Kearney. 2004. Development and selection of marginal zone B cells. Immunol. Rev. 197: 192-205.
46. Pillai, S., and A. Cariappa. 2009. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9: 767-777.
47. Stephan, R. P., C. R. Reilly, and P. L. Witte. 1998. Impaired ability of bone marrow stromal cells to support B-lymphopoiesis with age. Blood 91: 75-88.
48. Stephan, R. P., D. A. Lill-Elghanian, and P. L. Witte. 1997. Development of B cells in aged mice: decline in the ability of pro-B cells to respond to IL-7 but not to other growth factors. J. Immunol. 158: 1598-1609.
49. Frasca, D., D. Nguyen, R. L. Riley, and B. B. Blomberg. 2004. Effects of aging on DNA-binding activity of the E47 transcription factor in splenic B cells. Mech. Ageing Dev. 125: 111-112.
50. Frasca, D., D. Nguyen, R. L. Riley, and B. B. Blomberg. 2003. Effects of aging on proliferation and E47 transcription factor activity induced by different stimuli in murine splenic B cells. Mech. Ageing Dev. 124: 361-369.
51. Frasca, D., D. Nguyen, E. Van der Put, R. L. Riley, and B. B. Blomberg. 2003. The age-related decrease in E47 DNA-binding does not depend on increased Id inhibitory proteins in bonemarrow-derived B cell precursors. Front. Biosci. 8: a110-a116.
52. Johnson, S. A., S. J. Rozzo, and J. C. Cambier. 2002. Aging-dependent exclusion of antigen-inexperienced cells from the peripheral B cell repertoire. J. Immunol. 168: 5014-5023.
53. Traggiai, E., A. Casati, M. Frascoli, S. Porcellini, M. Ponzoni, F. Sanvito, L. Leng, R. Bucala, L. Moretta, and F. Grassi. 2010. Selective preservation of bone marrow mature recirculating but not marginal zone B cells in murine models of chronic inflammation. PLoS ONE 5: e11262.
54. Tortola, L., K. Yadava, M. F. Bachmann, C. Muller, J. Kisielow, and M. Kopf. 2010. IL-21 induces death of marginal zone B cells during chronic inflammation. Blood 116: 5200-5207.
55. Stephan, R. P., V. M. Sanders, and P. L. Witte. 1996. Stage-specific alterations in murine B lymphopoiesis with age. Int. Immunol. 8: 509-518.
56. Johnson, K. M., K. Owen, and P. L. Witte. 2002. Aging and developmental transitions in the B cell lineage. Int. Immunol. 14: 1313-1323.
57. Boehmer, E. D., J. Goral, D. E. Faunce, and E. J. Kovacs. 2004. Age-dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J. Leukoc. Biol. 75: 342-349.
58. Franceschi, C., M. Bonafè, S. Valensin, F. Olivieri, M. De Luca, E. Ottaviani, and G. De Benedictis. 2000. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908: 244-254.
59. Wang, S. L., M. Kutsche, G. DiSciullo, M. Schachner, and S. A. Bogen. 2000. Selective malformation of the splenic white pulp border in L1-deficient mice. J. Immunol. 165: 2465-2473.
60. Hoek, K. L., L. E. Gordy, P. L. Collins, V. V. Parekh, T. M. Aune, S. Joyce, J.W. Thomas, L. Van Kaer, and E. Sebzda. 2010. Follicular B cell trafficking within the spleen actively restricts humoral immune responses. Immunity 33: 254-265.
61. Girkontaite, I., V. Sakk, M. Wagner, T. Borggrefe, K. Tedford, J. Chun, and K. D. Fischer. 2004. The sphingosine-1-phosphate (S1P) lysophospholipid receptor S1P3 regulates MAdCAM-1+ endothelial cells in splenic marginal sinus organization. J. Exp. Med. 200: 1491-1501.
62. Singer, I. I., M. Tian, L. A. Wickham, J. Lin, S. S. Matheravidathu, M. J. Forrest, S. Mandala, and E. J. Quackenbush. 2005. Sphingosine-1-phosphate agonists increase macrophage homing, lymphocyte contacts, and endothelial junctional complex formation in murine lymph nodes. J. Immunol. 175: 7151-7161.